Consumer Staples [ 4/12 ] | Personal Care Products [ 43/75 ]
NYSE | Common Stock
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.
The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus.
In addition, it is the research and product development of skin care products, nutritional supplements, and devices.
The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers.
It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa.
Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 12, 26 | 0.29 Decreased by -23.61% | 0.33 Decreased by -12.03% |
| Nov 6, 25 | 0.34 Increased by +100.00% | 0.30 Increased by +13.33% |
| Aug 7, 25 | 0.43 Increased by +104.76% | 0.24 Increased by +79.17% |
| Jun 5, 25 | 2.14 Increased by +2.27 K% | 0.15 Increased by +1.32 K% |
| Feb 13, 25 | 0.38 Increased by +2.70% | 0.22 Increased by +72.73% |
| Nov 7, 24 | 0.17 Decreased by -69.64% | 0.20 Decreased by -15.00% |
| Aug 8, 24 | 0.21 Decreased by -61.11% | 0.17 Increased by +23.53% |
| May 8, 24 | 0.09 Decreased by -75.68% | 0.05 Increased by +80.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 370.32 M Decreased by -16.89% | 14.49 M Increased by +140.14% | Increased by +3.91% Increased by +148.29% |
| Sep 30, 25 | 364.21 M Decreased by -15.33% | 17.08 M Increased by +105.72% | Increased by +4.69% Increased by +142.96% |
| Jun 30, 25 | 386.14 M Decreased by -12.06% | 21.12 M Increased by +117.86% | Increased by +5.47% Increased by +120.31% |
| Mar 31, 25 | 364.49 M Decreased by -12.66% | 107.52 M Increased by +20.27 K% | Increased by +29.50% Increased by +23.19 K% |
| Dec 31, 24 | 445.55 M Decreased by -8.82% | -36.10 M Decreased by -595.81% | Decreased by -8.10% Decreased by -643.76% |
| Sep 30, 24 | 430.14 M Decreased by -13.76% | 8.30 M Increased by +122.47% | Increased by +1.93% Increased by +126.05% |
| Jun 30, 24 | 439.08 M Decreased by -12.23% | -118.26 M Decreased by -539.75% | Decreased by -26.93% Decreased by -601.02% |
| Mar 31, 24 | 417.31 M Decreased by -13.33% | -533.00 K Decreased by -104.69% | Decreased by -0.13% Decreased by -105.41% |